(19)
(11) EP 1 381 627 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
12.01.2011 Bulletin 2011/02

(45) Mention of the grant of the patent:
10.11.2010 Bulletin 2010/45

(21) Application number: 02720228.2

(22) Date of filing: 17.04.2002
(51) International Patent Classification (IPC): 
C07K 14/47(2006.01)
C07K 5/11(2006.01)
A61K 38/17(2006.01)
C07K 5/09(2006.01)
C07K 5/103(2006.01)
A61P 25/28(2006.01)
(86) International application number:
PCT/GB2002/001769
(87) International publication number:
WO 2002/083729 (24.10.2002 Gazette 2002/43)

(54)

POLYPEPTIDES DERIVED FROM AMYLOID PRECURSOR PEPTIDE (APP) AND THEIR USES

POLYPEPTIDE, ABGELEITET VON DER AMYLOID VORLÄUFERPROTEIN (APP), UND IHRE VERWENDUNGEN

POLYPEPTIDES DERIVES DU PRECURSEUR DE LA PROTEINE AMYLOIDE (AAP), ET LEUR UTILISATION


(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GR IE IT LI LU MC NL PT SE TR

(30) Priority: 18.04.2001 GB 0109558
17.08.2001 GB 0120084
30.11.2001 US 998491
28.03.2002 GB 0207387

(43) Date of publication of application:
21.01.2004 Bulletin 2004/04

(60) Divisional application:
10012535.0
10154130.8 / 2228387
10154171.2
10160807.3 / 2228388

(73) Proprietor: THE OPEN UNIVERSITY
Milton Keynes, Buckinghamshire MK7 6BJ (GB)

(72) Inventors:
  • MILEUSNIC, Radmila, c/o Dept. of Biological Sciences
    Milton Keynes MK7 6AA (GB)
  • ROSE, Steven Peter Russell, c/o Dept. of Biological Sciences
    Milton Keynes MK7 6AA (GB)

(74) Representative: W.P. Thompson & Co. 
55 Drury Lane
London WC2B 5SQ
London WC2B 5SQ (GB)


(56) References cited: : 
WO-A-94/09808
WO-A-97/04748
WO-A-98/21327
WO-A1-99/58564
WO-A-97/00063
WO-A-98/09985
WO-A-99/67284
US-A- 5 958 883
   
  • QUIBELL, MARTIN ET AL: "Solid-phase assembly of backbone amide-protected peptide segments: an efficient and reliable strategy for the synthesis of small protein" JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS 1: ORGANIC AND BIO-ORGANIC CHEMISTRY , CODEN: JCPRB4; ISSN: 0300-922X, vol. 11, 1996, pages 1227-1234, XP009067500
  • BECK-SICKINGER A G ET AL: "Sulfonation of arginine residues as side reaction in Fmoc-peptide synthesis" INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH 1991 DENMARK, vol. 38, no. 1, 1991, pages 25-31, XP000215705 ISSN: 0367-8377
  • WAKIMASU M ET AL: "USE OF THE 4 METHOXY-2 6-DIMETHYL BENZENESULFONYL GROUP TO SYNTHESIZE DYNORPHIN 1-13 AND RELATED PEPTIDES" CHEMICAL AND PHARMACEUTICAL BULLETIN (TOKYO), vol. 29, no. 9, 1981, pages 2592-2597, XP001246926 ISSN: 0009-2363
  • UKAI M ET AL: "Dynorphin A-(1-13) attenuates basal forebrain-lesion-induced amnesia in rats" BRAIN RESEARCH, vol. 625, no. 2, 22 October 1993 (1993-10-22), pages 355-356, XP002384245 ISSN: 0006-8993
  • NASHABEH W ET AL: "Studies in capillary zone electrophoresis with a post-column multiple capillary device for fraction collection and stepwise increase in electroosmotic flow during analysis" ELECTROPHORESIS, WILEY-VCH VERLAG, vol. 14, no. 5/6, May 1993 (1993-05), pages 407-416, XP009005692 WEINHEIM, DE ISSN: 0173-0835
  • PELSUE S ET AL: "Immunoreactivity between a monoclonal lupus autoantibody and the arginine/aspartic acid repeats within the U1-snRNP 70K autoantigen is conformationally restricted." JOURNAL OF PROTEIN CHEMISTRY. MAY 1994, vol. 13, no. 4, May 1994 (1994-05), pages 401-408, XP009005689 ISSN: 0277-8033
  • BOWNESS P ET AL: "Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27" EUROPEAN JOURNAL OF IMMUNOLOGY 1994 GERMANY, vol. 24, no. 10, 1994, pages 2357-2363, XP001031299 ISSN: 0014-2980
  • YAMAMOTO K ET AL: "THE SURVIVAL OF RAT CEREBRAL CORTICAL NEURONS IN THE PRESENCE OF TROPHIC APP PEPTIDES" JOURNAL OF NEUROBIOLOGY, JOHN WILEY AND SONS., NEW YORK, NY, US, vol. 25, no. 5, May 1994 (1994-05), pages 585-594, XP001107074 ISSN: 0022-3034
  • JIN L-W ET AL: "PEPTIDES CONTAINING THE RERMS SEQUENCE OF AMYLOID SS/A4 PROTEIN PRECURSOR BIND CELL SURFACE AND PROMOTE NEURITE EXTENSION" JOURNAL OF NEUROSCIENCE, NEW YORK, NY, US, vol. 14, no. 9, 1994, pages 5461-5470, XP000920917 ISSN: 0270-6474
  • MULTHAUP G ET AL: "Characterization of the high affinity heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP) and its enhancement by zinc(II)." JOURNAL OF MOLECULAR RECOGNITION, HEYDEN & SON LTD., vol. 8, no. 4, July 1995 (1995-07), pages 247-257, XP009005720 LONDON, GB ISSN: 0952-3499
  • MILEUSNIC R ET AL: "The role of APP in memory formation" EUROPEAN JOURNAL OF NEUROSCIENCE, vol. 12, no. Supplement 11, 24 June 2000 (2000-06-24), page 314, XP009067508 & MEETING OF THE FEDERATION OF EUROPEAN NEUROSCIENCE SOCIETIES; BRIGHTON, UK; JUNE 24-28, 2000 ISSN: 0953-816X
  • MILEUSNIC R ET AL: "The peptide sequence Arg-Glu-Arg, present in the amyloid precursor protein, protects against memory loss caused by Abeta and acts as a cognitive enhancer" EUROPEAN JOURNAL OF NEUROSCIENCE, vol. 19, no. 7, April 2004 (2004-04), pages 1933-1938, XP002383860 ISSN: 0953-816X
  • MILEUSNIC R ET AL: "Amyloid precursor protein: from synaptic plasticity to Alzheimer's disease." ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, vol. 1048, June 2005 (2005-06), pages 149-165, XP002384155 ISSN: 0077-8923
  • RIST BEATE ET AL: "The bioactive conformation of neuropeptide Y analogues at the human Y-2-receptor." EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 247, no. 3, 1997, pages 1019-1028, XP001135256 ISSN: 0014-2956
  • CURTAIN, CYRIL C. ET AL: "Fusogenic activity of amino-terminal region of HIV type 1 Nef protein" AIDS RESEARCH AND HUMAN RETROVIRUSES (1994), 10(10), 1231-40, October 1994 (1994-10), XP009005690
  • NINOMIYA, HARUAKI ET AL: "Amino acid sequence RERMS represents the active domain of amyloid.beta./A4 protein precursor that promotes fibroblast growth" JOURNAL OF CELL BIOLOGY (1993), 121(4), 879-86, 1993, XP009005688 cited in the application
  • JAMES, J. A. ET AL: "Basic amino acids predominate in the sequential autoantigenic determinant of the small nuclear 70K ribonucleoprotein" SCANDINAVIAN JOURNAL OF IMMUNOLOGY (1994), 39(6), 557-66, 1994, XP009005691
  • MERRIFIELD B: "SOLID PHASE SYNTHESIS" SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, vol. 232, 18 April 1986 (1986-04-18), pages 341-347, XP000985292 ISSN: 0036-8075
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).